Clinical Trial Update: Effects of Transdermal Scopolamine on Occupational Performance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating transdermal scopolamine for improving occupational performance in motion sickness; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Motion Sickness

Drugs mentioned

• TRANSDERM SCOP (SCOPOLAMINE)

Snippet

Sponsor: Boston University | Conditions: Motion Sickness | Phase 2 | Status: COMPLETED